Clinical Trials | September 17, 2025
Enveric clears FDA feedback milestone, prepares IND submission for EB-003
IND application for EB-003 expected in early 2026
IND application for EB-003 expected in early 2026
Lenalidomide Capsules are indicated for the treatment of adult patients with Multiple myeloma
A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
This strategic collaboration represents the third clinical trial under Senhwa’s five-year NCI-sponsored cancer research program
Ascletis announces ultra-long-acting subcutaneous depot maintenance formulation of small molecule GLP-1R agonist ASC30 with 75-Day observed half-life in participants with obesity
Late-breaking data presented at WCLC highlight significant and sustained improvements in overall survival, including more than doubling five-year survival rates compared to chemotherapy alone
Element5’s Agentic AI platform will be integrated with the HCHB EHR
Philips and Masimo will also collaborate on the development and co-promotion of next-generation monitoring solutions
The conference stressed a multi-dimensional approach required to address Antimicrobial Resistance (AMR), focusing on the right approach and strengthening awareness
The hospital was recognised as a Winner (Medium) in the category of Best Academic Institution (Government/Private)
Subscribe To Our Newsletter & Stay Updated
